Your browser doesn't support javascript.
loading
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Itzykson, Raphael; Thépot, Sylvain; Quesnel, Bruno; Dreyfus, Francois; Beyne-Rauzy, Odile; Turlure, Pascal; Vey, Norbert; Recher, Christian; Dartigeas, Caroline; Legros, Laurence; Delaunay, Jacques; Salanoubat, Célia; Visanica, Sorin; Stamatoullas, Aspasia; Isnard, Francoise; Marfaing-Koka, Anne; de Botton, Stephane; Chelghoum, Youcef; Taksin, Anne-Laure; Plantier, Isabelle; Ame, Shanti; Boehrer, Simone; Gardin, Claude; Beach, C L; Adès, Lionel; Fenaux, Pierre.
  • Itzykson R; Clinique Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.
Blood ; 117(2): 403-11, 2011 Jan 13.
Article en En | MEDLINE | ID: mdl-20940414
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2011 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2011 Tipo del documento: Article